Navigation Links
Analog thermal printer, Mitsubishi (115/230V) for BioDoc-It and VisiDoc-It Imaging Systems from UVP

ProductsAnalog thermal printer, Mitsubishi (115/230V) for BioDoc-It and VisiDoc-It Imaging Systems from UVP
Company UVP
Item Analog thermal printer, Mitsubishi (115/230V) for BioDoc-It and VisiDoc-It Imaging Systems
Price 
Description Conveniently document gels, films and membranes with a high quality thermal printer.
  • Compact, footprint printer
  • Supplies 256 gray scale for high resolution, archive-quality thermal film prints
  • Process low-cost prints in seconds
Info UVPUVP
UVP, Inc.
2066 W. 11th Street
Upland, CA 91786
USA

Call UVP to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-290-5789
Customer Service:
US: (800)452-6788
UK / Europe: +44(0)1223-420022
Fax Number: (909)946-3597
Web Site: http://www.uvp.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. RNA Cap Analog, Trimethylated from EPICENTRE Biotechnologies
2. RNA Cap Analog, Unmethylated from EPICENTRE Biotechnologies
3. RNA Cap Analog, Methylated from EPICENTRE Biotechnologies
4. ARCA (Anti Reverse Cap Analog) from Ambion
5. m7G(5)ppp(5)G (Cap Analog) from Ambion
6. m7G(5)ppp(5)G (Cap Analog) from Ambion
7. Analog thermal printer, Mitsubishi (115V) for all UVP imaging systems except BioDoc-It and VisiDoc-It from UVP
8. Analog thermal printer, Sony (230V) for DigiDoc-It, MultiDoc-It and ChromaDoc-It Imaging Systems from UVP
9. ARCA (Anti Reverse Cap Analog) from Ambion
10. m7G(5)ppp(5)G (Cap Analog) from Ambion
11. Mastercycler ep gradient S thermal cycler from Eppendorf North America
... Immulon 2HB ELISA strips, high binding ... affinity for hydrophilic proteins and complexes. ... for reagent injection while providing the ... Each strip accomodates 12 wells., ...
...
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid, Molecular Biology Grade...
... efficiencies and the chemistry of light production ... benefit that they require simple triggering conditions ... This benefit has been exploited to great ... compounds can also be easily modified to ...
Biology Products:
(Date:4/17/2014)... trials to treat tuberculosis could be the basis for ... bacteria, fungal infections and parasites, yet evade resistance, according ... collaborators. , Led by U. of I. chemistry professor ... drug SQ109 attacks the tuberculosis bacterium, how the drug ... to malaria and how targeting multiple pathways reduces ...
(Date:4/17/2014)... 17, 2014The development of stem cell therapies to cure ... characterize stem cell populations based on cell surface markers. ... new marker that is highly expressed in a type ... which they describe in an article in BioResearch ... Liebert, Inc., publishers. The article is available free on ...
(Date:4/17/2014)... Marc Andr Gauthier and Professor Luca Razzari of ... been awarded large grants from the John R. ... Innovation (CFI) for the acquisition of state-of-the-art biotech ... added matching grants from the Ministre de l,Enseignement ... de la Technologie (MESRST). These new laboratories will ...
Breaking Biology News(10 mins):Multitarget TB drug could treat other diseases, evade resistance 2New state-of-the-art biotech and nanotech equipment for INRS 2
... the body, a virus such as HIV invades body cells ... Once inside the cell, the invading microbe's genetic material takes ... more copies of the virus, which then spill out to ... that once a virus begins fusing with a cell's membrane, ...
... in prospect with a clinical drug trial to begin in ... would open the way to relief in the 10% of ... over 500,000,000 people. , The Walter and Eliza Hall ... Guinea Institute of Medical Research (PNGIMR) and the University of ...
... Medical Center (SFVAMC) and the University of California, San ... bronchitis, which is thought to lead to obliterative bronchitis ... transplanted lungs. , The researchers hope their results will ... standard test for chronic lung rejection, as well as ...
Cached Biology News:Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development 2Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development 3Old drug, new tricks: Prospects for slashing the impact of malaria 2Researchers identify genes associated with lung transplant rejection 2
(Date:1/14/2014)... DC (PRWEB) January 14, 2014 Carahsoft ... for Thursday, January 23, 2014 at 2pm EST (11am ... Knowledge.” The topic focuses on how technology can turn ... critical decisions for government agencies. The online webinar will ...
(Date:1/14/2014)... January 14, 2014 EquitiesIQ, a leading ... (OTCQB: ALQA). Alliqua is an emerging biomedical company acquiring, ... wound care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... a seasoned management team and Board, which launched the ...
(Date:1/14/2014)... 14, 2014 In recent years, growing ... methods in product development and promotion has led to ... mistrust, fueled by concerns about the insidious impact of ... of spectacular fines to the world’s biggest pharmas for ...
(Date:1/14/2014)... UK (PRWEB) January 13, 2014 Bob ... with more than 20 years in the industry, has ... photonics . Hainsey will serve as the society’s Science ... Dr. Hainsey join SPIE as our Technology Strategist, further ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2